RESUMEN
In order to establish firm evidence for the health effects of dietary polyphenol consumption, it is essential to have quantitative information regarding their dietary intake. The usefulness of the current methods, which rely mainly on the assessment of polyphenol intake using food records and food composition tables, is limited as they fail to assess total intake accurately. This review highlights the problems associated with such methods with regard to polyphenol-intake predictions. We suggest that the development of biological biomarkers, measured in both blood and urine, are essential for making accurate estimates of polyphenol intake. However, the relationship between dietary intakes and nutritional biomarkers are often highly complex. This review identifies the criteria that must be considered in the development of such biomarkers. In addition, we provide an assessment of the limited number of potential biomarkers of polyphenol intake currently available.
Asunto(s)
Dieta , Flavonoides/análisis , Fenoles/análisis , Biomarcadores/análisis , Biomarcadores/sangre , Biomarcadores/orina , Encuestas sobre Dietas , Flavonoides/administración & dosificación , Flavonoides/sangre , Flavonoides/metabolismo , Flavonoides/orina , Humanos , Hidroxibenzoatos/análisis , Hidroxibenzoatos/sangre , Hidroxibenzoatos/orina , Evaluación Nutricional , Fenoles/administración & dosificación , Fenoles/metabolismo , Polifenoles , Proyectos de InvestigaciónRESUMEN
The free radical theory of ageing postulates that age-associated neurodegeneration is caused by an imbalance between pro-oxidants and antioxidants resulting in oxidative stress. The current study showed regional variation in brain susceptibility to age-associated oxidative stress as shown by increased lipofuscin deposition and protein carbonyl levels in male rats of age 15-16 months compared to control ones (3-5 months). The hippocampus is the area most vulnerable to change compared to the cortex and cerebellum. However, proteasomal enzyme activity was not affected by age in any of the brain regions studied. Treatment with melatonin or coenzyme Q10 for 4 weeks reduced the lipofuscin content of the hippocampus and carbonyl level. However, both melatonin and coenzyme Q10 treatments inhibited beta-glutamyl peptide hydrolase activity. This suggests that these molecules can alter proteasome function independently of their antioxidant actions.
Asunto(s)
Envejecimiento/metabolismo , Antioxidantes/farmacología , Encéfalo/metabolismo , Lipofuscina/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Complejo de la Endopetidasa Proteasomal/metabolismo , Envejecimiento/efectos de los fármacos , Animales , Encéfalo/efectos de los fármacos , Coenzimas , Activación Enzimática/efectos de los fármacos , Masculino , Melatonina/farmacología , Oxidación-Reducción/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Ratas , Ratas Wistar , Distribución Tisular , Ubiquinona/análogos & derivados , Ubiquinona/farmacologíaRESUMEN
Flavonoids have been proposed to act as beneficial agents in a multitude of disease states, including cancer, cardiovascular disease, and neurodegenerative disorders. The biological effect of these polyphenols and their in vivo circulating metabolites will ultimately depend on the extent to which they associate with cells, either by interactions at the membrane or more importantly their uptake. This review summarises the current knowledge on the cellular uptake of flavonoids and their metabolites with particular relevance to further intracellular metabolism and the generation of potential new bioactive forms. Uptake and metabolism of the circulating forms of flavanols, flavonols, and flavanones into cells of the skin, the brain, and cancer cells is reviewed and potential biological relevance to intracellular formed metabolites is discussed.
Asunto(s)
Flavonoides/metabolismo , Animales , Sistema Nervioso Central/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Humanos , Neoplasias/metabolismo , Oxidación-Reducción , Piel/metabolismo , Compuestos de Sulfhidrilo/metabolismoRESUMEN
Epicatechin is a flavan-3-ol that is commonly present in green teas, red wine, cocoa products, and many fruits, such as apples. There is considerable interest in the bioavailability of epicatechin after oral ingestion. In vivo studies have shown that low levels of epicatechin are absorbed and found in the circulation as glucuronides, methylated and sulfated forms. Recent research has demonstrated protective effects of epicatechin and one of its in vivo metabolites, 3'-O-methyl epicatechin, against neuronal cell death induced by oxidative stress. Thus, we are interested in the ability of ingested epicatechin to cross the blood brain barrier and target the brain. Rats were administered 100 mg/kg body weight/d epicatechin orally for 1, 5, and 10 d. Plasma and brain extracts were analyzed by HPLC with photodiode array detection and LC-MS/MS. This study reports the presence of the epicatechin glucuronide and 3'-O-methyl epicatechin glucuronide formed after oral ingestion in the rat brain tissue.